There has been an enormous interest in the development of alternative medicines for type 2 diabetes, specifically screening for phytochemicals with the ability to delay or prevent glucose absorption. The goal of the present study was to provide in vitro evidence for potential inhibition of a-glucosidase and a-amylase enzymes, of the Ethyl acetate extract of Garcinia mangostana and study its Total antioxidant capacity (TAC). The extract showed appreciable a-glucosidase inhibitory effect in a concentration-dependent manner (IC50 = 23.58 ± 1.69µg/ml) and a weak a-amylase inhibitory activity (IC50 = 4.3 ± 0.61 mg/ml). The results indicate higher TAC (expressed as ascorbic acid equivalent) of the Ethyl acetate extract possesses significant total antioxidant capacity equivalent to ascorbic acid at higher concentration. a- amylase and a-glucosidase inhibition may possibly be one of the mechanisms for the G. mangostana extracts to exert antidiabetic activity and indicates that it can be considered as a potential candidate for the management of type 2 diabetes mellitus.
Cite this article:
Godavari A, Amutha K. In vitro Antidiabetic Activity of Garcinia mangostana by Enzymatic Inhibition Assay. Research J. Pharm. and Tech. 2017; 10(2): 508-512. doi: 10.5958/0974-360X.2017.00101.9
Godavari A, Amutha K. In vitro Antidiabetic Activity of Garcinia mangostana by Enzymatic Inhibition Assay. Research J. Pharm. and Tech. 2017; 10(2): 508-512. doi: 10.5958/0974-360X.2017.00101.9 Available on: https://rjptonline.org/AbstractView.aspx?PID=2017-10-2-28